Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP539361.RAEfXUIzr90RWUHTN5G4pxuavB5A-b3IbmgFp0CXddhb0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP539361.RAEfXUIzr90RWUHTN5G4pxuavB5A-b3IbmgFp0CXddhb0130_assertion type Assertion NP539361.RAEfXUIzr90RWUHTN5G4pxuavB5A-b3IbmgFp0CXddhb0130_head.
- NP539361.RAEfXUIzr90RWUHTN5G4pxuavB5A-b3IbmgFp0CXddhb0130_assertion description "[Also apolipoproteins show major changes, with an increase in apolipoprotein A-I, A-IV, B, C, and E. Particularly the changes in apo C-II, which is an activator of the enzyme lipoprotein lipase (LPL), and apo C-III, an inhibitor of LPL, with an increase of the C-III to C-II ratio, might contribute to the impaired lipoprotein catabolism in NS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP539361.RAEfXUIzr90RWUHTN5G4pxuavB5A-b3IbmgFp0CXddhb0130_provenance.
- NP539361.RAEfXUIzr90RWUHTN5G4pxuavB5A-b3IbmgFp0CXddhb0130_assertion evidence source_evidence_literature NP539361.RAEfXUIzr90RWUHTN5G4pxuavB5A-b3IbmgFp0CXddhb0130_provenance.
- NP539361.RAEfXUIzr90RWUHTN5G4pxuavB5A-b3IbmgFp0CXddhb0130_assertion SIO_000772 15827892 NP539361.RAEfXUIzr90RWUHTN5G4pxuavB5A-b3IbmgFp0CXddhb0130_provenance.
- NP539361.RAEfXUIzr90RWUHTN5G4pxuavB5A-b3IbmgFp0CXddhb0130_assertion wasDerivedFrom befree-20150227 NP539361.RAEfXUIzr90RWUHTN5G4pxuavB5A-b3IbmgFp0CXddhb0130_provenance.
- NP539361.RAEfXUIzr90RWUHTN5G4pxuavB5A-b3IbmgFp0CXddhb0130_assertion wasGeneratedBy ECO_0000203 NP539361.RAEfXUIzr90RWUHTN5G4pxuavB5A-b3IbmgFp0CXddhb0130_provenance.